Autopsy report · NCT04964960

Pembro+Chemo in Brain Mets

“Slow Accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

John L. Villano, MD, PhD

Sponsor type

University, hospital or other

Conditions

Lung Cancer; Lung Cancer Metastatic; Brain Cancer; Cancer

Interventions

Pembrolizumab; Nab paclitaxel; Paclitaxel; Pemetrexed; Carboplatin

Participants

3

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.